Investigating the Mechanism of Action of Ipomoea pes-caprae in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology
Marine Drugs · 2025
DOI: 10.3390/md23030114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Fangfei Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Plant Extracts, Ipomoea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiagang Deng, Guangxi University of Chinese Medicine ‘Guipai Traditional Chinese Medicine Inheritance and Innovation Team’, The Talent Education Program of Guangxi Science and Technology Project.
Abstract (Originalsprache)
Ipomoea pes-caprae (L.) Sweet (Convolvulaceae) is a commonly used marine Chinese medicine in the coastal areas of southern China. Traditionally, it has been used in the treatment of rheumatoid arthritis (RA). However, the mechanism of action against RA remains unclear. This study aimed to explore the mechanism of action of Ipomoea pes-caprae water extract (IPE) in the treatment of RA through serum metabolomics and network pharmacology. Rat models of RA with wind-dampness cold bi-syndrome (WCM) and wind-dampness heat bi-syndrome (WHM) were established to evaluate the therapeutic effect of IPE against RA. Ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS) technology was used to analyze the absorbed components of IPE in the plasma of the two models. Serum metabolomics was employed to identify potential biomarkers and metabolic pathways of IPE in the treatment of RA. The key targets and related pathways of RA were screened using network pharmacology and validated using molecular docking. The biomarker-pathway-target network was mapped via the combination of metabolomics and network pharmacology. A total of 10 chemical constituents were identified from WHM rat plasma, and eight chemical constituents were identified from WCM rat plasma. Serum metabolomics research identified 20 endogenous potential biomarkers, and 10 major metabolic pathways closely related to WHM and WCM. Network pharmacology analysis yielded 65 overlapping targets, with the core targets being ALB, AKT1, EGFR, and CASP3. Molecular docking showed that the four absorbed components in plasma had a strong binding activity with ALB and AKT1. Combining metabolomics and network pharmacology, two major biomarkers and two major pathways were identified. IPE can effectively relieve the symptoms of RA, and the potential mechanism of IPE in treating RA has been preliminarily elucidated. These results can provide a scientific basis for further drug research and development, as well as clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica, Guangxi University of Chinese Medicine, Nanning 530200, China.
- University Engineering Research Center of Reutilization of Traditional Chinese Medicine Resources, Guangxi University of Chinese Medicine, Nanning 530200, China.
- Guangxi Key Laboratory of TCM Formulas Theory and Transformation for Damp Diseases, Guangxi University of Chinese Medicine, Nanning 530200, China.
- Department of Pharmaceutical, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
ORCID-Profile: Erwei Hao
Förderung
- Jiagang Deng
- Guangxi University of Chinese Medicine ‘Guipai Traditional Chinese Medicine Inheritance and Innovation Team’
- The Talent Education Program of Guangxi Science and Technology Project
Zitieren
APA
Zhong, F., Li, S., Pan, X., Wen, J., Xie, J., Du, Z., Hao, E., Deng, J., & Hou, X. (2025). Investigating the Mechanism of Action of Ipomoea pes-caprae in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology. Marine Drugs. https://doi.org/10.3390/md23030114
Vancouver
Zhong F, Li S, Pan X, Wen J, Xie J, Du Z, et al. Investigating the Mechanism of Action of Ipomoea pes-caprae in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology. Marine Drugs. 2025. doi:10.3390/md23030114
BibTeX
@article{Zhong2025,
author = {Zhong, Fangfei and Li, Siwei and Pan, Xianglong and Wen, Juan and Xie, Jinling and Du, Zhengcai and Hao, Erwei and Deng, Jiagang and Hou, Xiaotao},
title = {Investigating the Mechanism of Action of Ipomoea pes-caprae in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23030114}
}
EUVIMED